Ultralife's MACD Death Cross and Bearish Marubozu trigger negative momentum.
ByAinvest
Wednesday, Aug 13, 2025 12:51 pm ET1min read
ULBI--
The company's EPS for the quarter was 5 cents, significantly lower than the same period last year's 22 cents. The revenue shortfall was attributed to delayed orders, tariffs, and margin compression, as cited by CEO Mike Manna [2]. Analysts had lowered their mean earnings estimate by about 33.3% over the last three months, reflecting growing concerns about the company's performance [1].
Technical indicators also signal a potential continuation of the downtrend. According to the 15-minute chart for Ultralife, the Moving Average Convergence Divergence (MACD) indicator formed a death cross at 09:45 on August 7, 2025, suggesting a potential shift in momentum towards the downside [2]. Additionally, the KDJ (KST Divergence Indicator) also triggered a death cross at the same time, reinforcing the bearish signal [2]. These indicators suggest that the stock price has the potential to continue falling, potentially leading to further decreases in the stock price.
Investors should monitor key levels, such as the 200-day moving average at $7.08 and the support level at $6.28, as a close below $6.28 could trigger a test of the 52-week low [2]. While the CEO hinted at potential recovery in the second half of 2025, near-term risks remain elevated, and caution is warranted [2].
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TZ2IL:0-ultralife-corp-reports-results-for-the-quarter-ended-june-30-earnings-summary/
[2] https://www.ainvest.com/news/ultralife-plunges-20-34-fueling-selloff-earnings-disappointment-2508/
Ultralife's 15-minute chart has exhibited a MACD Death Cross and a Bearish Marubozu at 08/13/2025 12:45, indicating a potential for the stock price to continue its downward trajectory. The presence of sellers in control of the market suggests a continuation of bearish momentum.
Ultralife Corp (ULBI) reported its second-quarter earnings on August 7, 2025, with adjusted earnings per share (EPS) of 7 cents, falling short of the expected 14 cents per share. Revenue rose 13% to $48.56 million but missed the analysts' estimate of $51.00 million [1]. The stock price reacted negatively, falling by 9.1% in the quarter and gaining 9.5% year-to-date [1].The company's EPS for the quarter was 5 cents, significantly lower than the same period last year's 22 cents. The revenue shortfall was attributed to delayed orders, tariffs, and margin compression, as cited by CEO Mike Manna [2]. Analysts had lowered their mean earnings estimate by about 33.3% over the last three months, reflecting growing concerns about the company's performance [1].
Technical indicators also signal a potential continuation of the downtrend. According to the 15-minute chart for Ultralife, the Moving Average Convergence Divergence (MACD) indicator formed a death cross at 09:45 on August 7, 2025, suggesting a potential shift in momentum towards the downside [2]. Additionally, the KDJ (KST Divergence Indicator) also triggered a death cross at the same time, reinforcing the bearish signal [2]. These indicators suggest that the stock price has the potential to continue falling, potentially leading to further decreases in the stock price.
Investors should monitor key levels, such as the 200-day moving average at $7.08 and the support level at $6.28, as a close below $6.28 could trigger a test of the 52-week low [2]. While the CEO hinted at potential recovery in the second half of 2025, near-term risks remain elevated, and caution is warranted [2].
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TZ2IL:0-ultralife-corp-reports-results-for-the-quarter-ended-june-30-earnings-summary/
[2] https://www.ainvest.com/news/ultralife-plunges-20-34-fueling-selloff-earnings-disappointment-2508/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet